PALA, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 1.897
EU - Europa 1.225
AS - Asia 271
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.394
Nazione #
US - Stati Uniti d'America 1.895
PL - Polonia 560
IE - Irlanda 193
SE - Svezia 147
IT - Italia 143
HK - Hong Kong 92
RU - Federazione Russa 76
CN - Cina 61
JO - Giordania 44
SG - Singapore 39
FI - Finlandia 34
DE - Germania 18
CH - Svizzera 16
VN - Vietnam 14
GB - Regno Unito 13
UA - Ucraina 13
BE - Belgio 7
TR - Turchia 7
IN - India 4
IR - Iran 3
KR - Corea 3
CA - Canada 2
ES - Italia 2
FR - Francia 2
MM - Myanmar 2
MY - Malesia 2
EU - Europa 1
PT - Portogallo 1
Totale 3.394
Città #
Warsaw 560
Fairfield 291
Chandler 212
Dublin 193
Ashburn 166
Seattle 141
Woodbridge 135
Cambridge 128
Wilmington 108
Houston 95
Ann Arbor 70
Hong Kong 50
Altamura 48
Princeton 48
Lawrence 47
Buffalo 41
Boston 28
Beijing 27
Jacksonville 27
Singapore 27
Florence 24
San Diego 23
Kent 21
Medford 19
Shanghai 18
Bern 15
Los Angeles 15
Dong Ket 14
Moscow 14
Rome 14
Boardman 13
Falls Church 8
New York 8
Brussels 7
Norwalk 7
Andover 6
Izmir 6
Milan 4
Phoenix 4
West Jordan 4
Dearborn 3
London 3
Pune 3
Selvazzano Dentro 3
Seoul 3
Barcelona 2
Campi Bisenzio 2
Catania 2
Helsinki 2
Hillsboro 2
Kilburn 2
Marcallo con Casone 2
Munich 2
Naples 2
Shah Alam 2
Siena 2
Toronto 2
Yangon 2
Auburn Hills 1
Bolzano 1
Campagnano Di Roma 1
Centrale 1
Dalmine 1
Frankfurt Am Main 1
Guangzhou 1
Haining 1
Incisa 1
Ladispoli 1
Lappeenranta 1
Leawood 1
Mcallen 1
Nanjing 1
Nocera Superiore 1
Pavia 1
Redmond 1
Redwood City 1
Reggio Calabria 1
San Mateo 1
Santo Tirso 1
Shenzhen 1
Simi Valley 1
Wuhan 1
Zibo 1
Totale 2.752
Nome #
Fit and motivated: outcome predictors in patients starting a program for lifestyle change. 211
The role of DPP4 activity in cardiovascular districts: in vivo and in vitro evidence. 203
Inflammatory molecules affect the interaction between human dendritic cells and vascular smooth muscle cells 167
False and true pre-treatment predictors of weight loss in obese patients starting a program for lifestyle change. 155
The therapy of insulin resistance in other diseases besides type 2 diabetes. 144
Characterization of circulating and monocyte-derived dendritic cells in obese and diabetic patients 118
Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells. 117
Lower and higher-potency statins on glycemic control in type 2 diabetes: A retrospective cohort study 107
Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials 100
Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions. 97
Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study 86
Diabetic microangiopathy: IGFBP control endothelial cell growth by a common mechanism in spite of their species specificity and tissue peculiarity. 84
Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells 82
A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients 81
Failure to metformin and insulin secretagogue monotherapy: an observational cohort study. 80
Dendritic cell phenotype and function are modulated by inflammation and insulin-resistance. 80
Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials 76
Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. 75
Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients. 73
Glomerular hyperfiltration and metabolic syndrome: results from the FIrenze-BAgno A Ripoli (FIBAR) Study 73
Time to insulin in type-2 diabetes: high hurdles or Santiago way? 72
Clinical approach to diabetic cardiomyopathy: A review of human studies 72
Motivational enhancement therapy in obese patients: A promising application 70
Meccanismi infiammatori regolano le interazioni tra cellule muscolari coronariche lisce e cellule dendritiche umane 70
Insulin resistance and obesity affect monocyte-derived dendritic cell phenotype and function 69
Long-term interactive group education for type 1 diabetic patients 66
Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study. 65
Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. 65
National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study. 62
Studio del fenotipo delle cellule dendritiche di pazienti obesi ed insulino resistenti e della loro interazione con cellule muscolari lisce coronariche umane. 53
Doses of insulin and its analogues and cancer occurence in insulin-treated type 2 diabetic patients. 52
Role of insulin in the type 2 diabetes therapy: past, present and future. 52
Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials 46
Assessment of left ventricular global longitudinal strain in patients with type 2 diabetes: Relationship with microvascular damage and glycemic control 43
MANAGEMENT OF HYPERGLICEMIA IN TYPE 2 DIABETES: A CONSENSUS ALGORITHM FOR THE INITIATION AND ADJUSTMENT OF THERAPY: A CONSENSUS STATEMENT FROM THE AMERICAN DIABETES ASSOCIATION AND THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES 42
Periodontitis predicts HbA1c levels and glucose variability in type 1 diabetic patients: the PARODIA Florence Project study 40
Characterization of dendritic cells in obese and diabetic patients 37
Body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR) e waist body mass index (wBMI): Which is better? 36
Online group lifestyle modification programs for obesity during the COVID-19 pandemic: The EDucation ONline (EDON) retrospective study 33
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS) 32
Patient-Reported Outcomes of COVID-19 Vaccine Breakthrough Infection-Associated Changes in Glucose Control in Subjects With Type 1 Diabetes (PRO-VACS 2 Study) 29
Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study-The "PAROdontopatia e DIAbete" (PARODIA) project 28
Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study—The “PAROdontopatia e DIAbete” (PARODIA) project 24
Obesity therapy: How and why? 21
The "slower" the better 19
Orthorexia nervosa and type 1 diabetes: results of a cross-sectional study 18
Totale 3.425
Categoria #
all - tutte 10.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.705


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020692 0 62 22 59 97 82 85 90 78 59 48 10
2020/2021374 39 34 17 33 17 32 24 28 46 51 22 31
2021/2022282 9 7 23 5 11 18 6 16 17 25 56 89
2022/2023889 74 178 38 76 46 152 110 42 122 4 20 27
2023/2024320 17 33 49 17 14 53 19 62 7 17 26 6
2024/2025132 85 47 0 0 0 0 0 0 0 0 0 0
Totale 3.425